Eitan Neidich, Alon B. Neidich, David A. Axelrod, MD, and John P. Roberts, MD
Geographic disparities in availability of organs for transplant have spawned for-profit companies that help patients get on waitlists in more than one region and arrange travel for them if an organ becomes available.
Reporting of post-CABG mortality rates has resulted in a decrease in in-hospital mortality, and non-outcome-based measures of care quality show promise of improving patient satisfaction.
AMA J Ethics. 2015;17(7):647-650. doi:
10.1001/journalofethics.2015.17.7.stas2-1507.
The United States government’s insistence that organs can only be procured through altruism, rather than being exchanged or purchased, contributes to the very exploitation of people of color in developing countries it sought to prevent.